Wednesday 16 March 2016

Latest Study On ELITech Group - Product Pipeline Analysis, 2016 Update

Summary

ELITech Group (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The companys products portfolio includes clinical chemistry, cytology, hematology, immunology, microbiology and molecular diagnostics. Its clinical chemistry products include chemistry systems, open chemistry reagents, cystic fibrosis sweat tests, obstetric and pregnancy reagents, and osmometers. ELITech also offers various medical condition products such as bleeding and thrombotic disorders, human genetic, infectious diseases, streptococcus infections, anemia, autoimmune diseases, cancer, cardiovascular diseases, fungal infections, liver diseases and urinary tract infections, among others. The company serves clinical chemistry, microbiology, immunology, and molecular biology markets. It has operations in France, Brazil, the UK, the Netherlands, Italy and the US. Elitech is headquartered in Puteaux, France.


This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ELITech Group
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline


- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)